~~<i id='E80CD4743E'><strike id='E80CD4743E'><tt id='E80CD4743E'><pre id='E80CD4743E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：entertainment 2025-09-30 01:02:10 - browse：26678

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Ending health disparities requires full federal government, panel says

explore

leisure time

explore

hotspot

explore

leisure time

TraderJoe'srecalledover10,000casesofitsbroccolicheddarsoup.TraderJoe'sTraderJoe'shasissuedavolu

WSS

Researchers explore possible ties between long Covid, menopause

Ford recalls 870K F

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

Hospital price transparency does save money, advocate argues

CEOs share strategies for surviving biotech slump

Alexander Hamilton and the argument for universal insurance

hotspot

knowledge

explore

United colonoscopy coverage change 'may cost lives,' doctors say

HHS leader on health, climate change and biopharma emissions

Hepatitis C has a cure — but many Americans still lack access to it

Solve the antibiotic resistance crisis with preventive drugs

Tori Bowie and the unacceptable rates of Black maternal death

Ford recalls 870K F

Malaria cases in Florida and Texas: Here’s what you need to know

The mammogram wars are not over

23andMe had bad news about my health. I wish a person had delivered it

Studies point to risks of excluding people with obesity from drug trials

leisure time

Medicare reduced heart disease by changing how it pays doctors

Marc Tessier

Ford recalls 870K F

Solve the antibiotic resistance crisis with preventive drugs

STAT Summit: Biotech founders on deal

Hospital price transparency does save money, advocate argues

explore

hotspot

explore

leisure time